{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:27:56Z","timestamp":1783711676399,"version":"3.55.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T00:00:00Z","timestamp":1671753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["National Research Foundation of Korea"],"award-info":[{"award-number":["National Research Foundation of Korea"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11033-022-08175-6","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T04:20:35Z","timestamp":1671769235000},"page":"2127-2136","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["CRISPR-Cas9 mediated genome editing of Huntington\u2019s disease neurospheres"],"prefix":"10.1007","volume":"50","author":[{"given":"Ji Yun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewoo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoori","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooseok","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7100-0057","authenticated-orcid":false,"given":"Jae-Jun","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Joon","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,23]]},"reference":[{"issue":"10","key":"8175_CR1","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles C, Bates GP (2004) Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series. EMBO Rep 5(10):958\u2013963. https:\/\/doi.org\/10.1038\/sj.embor.7400250","journal-title":"EMBO Rep"},{"issue":"4","key":"8175_CR2","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/ng0893-398","volume":"4","author":"SE Andrew","year":"1993","unstructured":"Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilmann J, Adam S et al (1993) The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington\u2019s disease. Nat Genet 4(4):398\u2013403. https:\/\/doi.org\/10.1038\/ng0893-398","journal-title":"Nat Genet"},{"issue":"4","key":"8175_CR3","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/ng0893-387","volume":"4","author":"M Duyao","year":"1993","unstructured":"Duyao M, Ambrose C, Myers R, Novelletto A, Persichetti F, Frontali M et al (1993) Trinucleotide repeat length instability and age of onset in Huntington\u2019s disease. Nat Genet 4(4):387\u2013392. https:\/\/doi.org\/10.1038\/ng0893-387","journal-title":"Nat Genet"},{"issue":"42","key":"8175_CR4","doi-asserted-by":"publisher","first-page":"9773","DOI":"10.1523\/JNEUROSCI.3183-05.2005","volume":"25","author":"M Diaz-Hernandez","year":"2005","unstructured":"Diaz-Hernandez M, Torres-Peraza J, Salvatori-Abarca A, Moran MA, Gomez-Ramos P, Alberch J et al (2005) Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington\u2019s disease. J Neurosci 25(42):9773\u20139781. https:\/\/doi.org\/10.1523\/JNEUROSCI.3183-05.2005","journal-title":"J Neurosci"},{"issue":"1","key":"8175_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","volume":"101","author":"A Yamamoto","year":"2000","unstructured":"Yamamoto A, Lucas JJ, Hen R (2000) Reversal of neuropathology and motor dysfunction in a conditional model of Huntington\u2019s disease. Cell 101(1):57\u201366. https:\/\/doi.org\/10.1016\/S0092-8674(00)80623-6","journal-title":"Cell"},{"issue":"9","key":"8175_CR6","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS et al (2000) Decreased expression of striatal signaling genes in a mouse model of Huntington\u2019s disease. Hum Mol Genet 9(9):1259\u20131271. https:\/\/doi.org\/10.1093\/hmg\/9.9.1259","journal-title":"Hum Mol Genet"},{"issue":"5","key":"8175_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/s0168-9525(03)00074-x","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars KL, Rubinsztein DC (2003) Transcriptional abnormalities in Huntington disease. Trends Genet 19(5):233\u2013238. https:\/\/doi.org\/10.1016\/s0168-9525(03)00074-x","journal-title":"Trends Genet"},{"issue":"1","key":"8175_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127(1):59\u201369. https:\/\/doi.org\/10.1016\/j.cell.2006.09.015","journal-title":"Cell"},{"issue":"142","key":"8175_CR9","doi-asserted-by":"publisher","first-page":"142ra97","DOI":"10.1126\/scitranslmed.3003799","volume":"4","author":"T Tsunemi","year":"2012","unstructured":"Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA et al (2012) PGC-1alpha rescues Huntington\u2019s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4(142):142ra97. https:\/\/doi.org\/10.1126\/scitranslmed.3003799","journal-title":"Sci Transl Med"},{"issue":"5529","key":"8175_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L et al (2001) Loss of huntingtin-mediated BDNF gene transcription in Huntington\u2019s disease. Science 293(5529):493\u2013498. https:\/\/doi.org\/10.1126\/science.1059581","journal-title":"Science"},{"issue":"44","key":"8175_CR11","doi-asserted-by":"publisher","first-page":"14708","DOI":"10.1523\/jneurosci.1637-10.2010","volume":"30","author":"Y Xie","year":"2010","unstructured":"Xie Y, Hayden MR, Xu B (2010) BDNF overexpression in the forebrain rescues Huntington\u2019s disease phenotypes in YAC128 mice. J Neurosci 30(44):14708\u201314718. https:\/\/doi.org\/10.1523\/jneurosci.1637-10.2010","journal-title":"J Neurosci"},{"issue":"1","key":"8175_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.nbd.2010.08.017","volume":"41","author":"T Hathorn","year":"2011","unstructured":"Hathorn T, Snyder-Keller A, Messer A (2011) Nicotinamide improves motor deficits and upregulates PGC-1alpha and BDNF gene expression in a mouse model of Huntington\u2019s disease. Neurobiol Dis 41(1):43\u201350. https:\/\/doi.org\/10.1016\/j.nbd.2010.08.017","journal-title":"Neurobiol Dis"},{"issue":"1","key":"8175_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.expneurol.2007.10.015","volume":"210","author":"Q Peng","year":"2008","unstructured":"Peng Q, Masuda N, Jiang M, Li Q, Zhao M, Ross CA et al (2008) The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6\/2 Huntington\u2019s disease mouse model. Exp Neurol 210(1):154\u2013163. https:\/\/doi.org\/10.1016\/j.expneurol.2007.10.015","journal-title":"Exp Neurol"},{"issue":"6213","key":"8175_CR14","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096. https:\/\/doi.org\/10.1126\/science.1258096","journal-title":"Science"},{"issue":"4","key":"8175_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nbt.2842","volume":"32","author":"JD Sander","year":"2014","unstructured":"Sander JD, Joung JK (2014) CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32(4):347\u2013355. https:\/\/doi.org\/10.1038\/nbt.2842","journal-title":"Nat Biotechnol"},{"issue":"6121","key":"8175_CR16","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE et al (2013) RNA-guided Hum genome Eng via Cas9 Sci 339(6121):823\u2013826. https:\/\/doi.org\/10.1126\/science.1232033","journal-title":"RNA-guided Hum genome Eng via Cas9 Sci"},{"issue":"5","key":"8175_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nrg3899","volume":"16","author":"O Shalem","year":"2015","unstructured":"Shalem O, Sanjana NE, Zhang F (2015) High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet 16(5):299\u2013311. https:\/\/doi.org\/10.1038\/nrg3899","journal-title":"Nat Rev Genet"},{"key":"8175_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","volume":"11","author":"B Gyorgy","year":"2018","unstructured":"Gyorgy B, Loov C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C et al (2018) CRISPR\/Cas9 mediated disruption of the swedish APP allele as a Therapeutic Approach for early-onset Alzheimer\u2019s Disease. Mol Ther Nucleic Acids 11:429\u2013440. https:\/\/doi.org\/10.1016\/j.omtn.2018.03.007","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"8175_CR19","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","volume":"22","author":"H Park","year":"2019","unstructured":"Park H, Oh J, Shim G, Cho B, Chang Y, Kim S et al (2019) In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease. Nat Neurosci 22(4):524\u2013528. https:\/\/doi.org\/10.1038\/s41593-019-0352-0","journal-title":"Nat Neurosci"},{"issue":"11","key":"8175_CR20","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1016\/j.ymthe.2018.08.019","volume":"26","author":"B Kantor","year":"2018","unstructured":"Kantor B, Tagliafierro L, Gu J, Zamora ME, Ilich E, Grenier C et al (2018) Downregulation of SNCA expression by targeted editing of DNA methylation: a potential strategy for Precision Therapy in PD. Mol Ther 26(11):2638\u20132649. https:\/\/doi.org\/10.1016\/j.ymthe.2018.08.019","journal-title":"Mol Ther"},{"issue":"5","key":"8175_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s13238-017-0397-3","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Yi F, Fu L, Yang J, Wang S, Wang Z et al (2017) CRISPR\/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Protein Cell 8(5):365\u2013378. https:\/\/doi.org\/10.1007\/s13238-017-0397-3","journal-title":"Protein Cell"},{"key":"8175_CR22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.omtn.2019.07.009","volume":"17","author":"FK Ekman","year":"2019","unstructured":"Ekman FK, Ojala DS, Adil MM, Lopez PA, Schaffer DV, Gaj T (2019) CRISPR-Cas9-Mediated genome editing increases Lifespan and Improves Motor deficits in a Huntington\u2019s Disease Mouse Model. Mol Ther Nucleic Acids 17:829\u2013839. https:\/\/doi.org\/10.1016\/j.omtn.2019.07.009","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"8175_CR23","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/0963689719840662","volume":"28","author":"GL Dunbar","year":"2019","unstructured":"Dunbar GL, Koneru S, Kolli N, Sandstrom M, Maiti P, Rossignol J (2019) Silencing of the mutant huntingtin gene through CRISPR-Cas9 improves the mitochondrial biomarkers in an in vitro model of Huntington\u2019s Disease. Cell Transpl 28(4):460\u2013463. https:\/\/doi.org\/10.1177\/0963689719840662","journal-title":"Cell Transpl"},{"key":"8175_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnins.2018.00075","volume":"12","author":"M Dabrowska","year":"2018","unstructured":"Dabrowska M, Juzwa W, Krzyzosiak WJ, Olejniczak M (2018) Precise excision of the CAG tract from the huntingtin gene by Cas9 nickases. Front Neurosci 12:75. https:\/\/doi.org\/10.3389\/fnins.2018.00075","journal-title":"Front Neurosci"},{"key":"8175_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.brainres.2012.07.026","volume":"1473","author":"A Reiner","year":"2012","unstructured":"Reiner A, Wang HB, Del Mar N, Sakata K, Yoo W, Deng YP (2012) BDNF may play a differential role in the protective effect of the mGluR2\/3 agonist LY379268 on striatal projection neurons in R6\/2 Huntington\u2019s disease mice. Brain Res 1473:161\u2013172. https:\/\/doi.org\/10.1016\/j.brainres.2012.07.026","journal-title":"Brain Res"},{"key":"8175_CR26","doi-asserted-by":"publisher","first-page":"118061","DOI":"10.1016\/j.lfs.2020.118061","volume":"257","author":"BMV Pereira","year":"2020","unstructured":"Pereira BMV, Thieme K, de Araujo L, Rodrigues AC (2020) Lack of adiponectin in mice accelerates high-fat diet-induced progression of chronic kidney disease. Life Sci 257:118061. https:\/\/doi.org\/10.1016\/j.lfs.2020.118061","journal-title":"Life Sci"},{"issue":"3","key":"8175_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.3101","volume":"19","author":"L Shi","year":"2013","unstructured":"Shi L, Cui S, Engel JD, Tanabe O (2013) Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nat Med 19(3):291\u2013294. https:\/\/doi.org\/10.1038\/nm.3101","journal-title":"Nat Med"},{"issue":"10","key":"8175_CR28","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/s1474-4422(17)30280-6","volume":"16","author":"EJ Wild","year":"2017","unstructured":"Wild EJ, Tabrizi SJ (2017) Therapies targeting DNA and RNA in Huntington\u2019s disease. Lancet Neurol 16(10):837\u2013847. https:\/\/doi.org\/10.1016\/s1474-4422(17)30280-6","journal-title":"Lancet Neurol"},{"issue":"6","key":"8175_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/mt.2009.17","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, McBride JL, Martins I, Shen S, Xing Y, Carter BJ et al (2009) Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington\u2019s disease mice. Mol Ther 17(6):1053\u20131063. https:\/\/doi.org\/10.1038\/mt.2009.17","journal-title":"Mol Ther"},{"issue":"12","key":"8175_CR30","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1038\/mt.2011.201","volume":"19","author":"JB Carroll","year":"2011","unstructured":"Carroll JB, Warby SC, Southwell AL, Doty CN, Greenlee S, Skotte N et al (2011) Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene \/ allele-specific silencing of mutant huntingtin. Mol Ther 19(12):2178\u20132185. https:\/\/doi.org\/10.1038\/mt.2011.201","journal-title":"Mol Ther"},{"issue":"3","key":"8175_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/ana.21569","volume":"65","author":"V Drouet","year":"2009","unstructured":"Drouet V, Perrin V, Hassig R, Dufour N, Auregan G, Alves S et al (2009) Sustained effects of nonallele-specific huntingtin silencing. Ann Neurol 65(3):276\u2013285. https:\/\/doi.org\/10.1002\/ana.21569","journal-title":"Ann Neurol"},{"issue":"16","key":"8175_CR32","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1073\/pnas.0501507102","volume":"102","author":"SQ Harper","year":"2005","unstructured":"Harper SQ, Staber PD, He X, Eliason SL, Martins IH, Mao Q et al (2005) RNA interference improves motor and neuropathological abnormalities in a Huntington\u2019s disease mouse model. Proc Natl Acad Sci U S A 102(16):5820\u20135825. https:\/\/doi.org\/10.1073\/pnas.0501507102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"8175_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA et al (2012) Sustained therapeutic reversal of Huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74(6):1031\u201344. https:\/\/doi.org\/10.1016\/j.neuron.2012.05.009","journal-title":"Neuron"},{"key":"8175_CR34","doi-asserted-by":"publisher","first-page":"1452696","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-P\u00e9rez","year":"2020","unstructured":"Rius-P\u00e9rez S, Torres-Cuevas I, Mill\u00e1n I, Ortega \u00c1L, P\u00e9rez S (2020) PGC-1\u03b1, inflammation, and oxidative stress: an integrative view in metabolism. Oxid Med Cell Longev 2020:1452696. https:\/\/doi.org\/10.1155\/2020\/1452696","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"8175_CR35","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cmet.2005.03.002","volume":"1","author":"Z Arany","year":"2005","unstructured":"Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O et al (2005) Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1(4):259\u2013271. https:\/\/doi.org\/10.1016\/j.cmet.2005.03.002","journal-title":"Cell Metab"},{"issue":"3","key":"8175_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1172\/JCI27794","volume":"116","author":"BN Finck","year":"2006","unstructured":"Finck BN, Kelly DP (2006) PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J Clin Invest 116(3):615\u2013622. https:\/\/doi.org\/10.1172\/JCI27794","journal-title":"J Clin Invest"},{"issue":"4","key":"8175_CR37","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1101\/gad.1177604","volume":"18","author":"DP Kelly","year":"2004","unstructured":"Kelly DP, Scarpulla RC (2004) Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev 18(4):357\u2013368. https:\/\/doi.org\/10.1101\/gad.1177604","journal-title":"Genes Dev"},{"issue":"1","key":"8175_CR38","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V et al (1999) Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98(1):115\u2013124. https:\/\/doi.org\/10.1016\/S0092-8674(00)80611-X","journal-title":"Cell"},{"key":"8175_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Flint Beal M (2013) PGC-1\u03b1, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med 62:37\u201346. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2013.04.016","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"8175_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP et al (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118(1):127\u2013138. https:\/\/doi.org\/10.1016\/j.cell.2004.06.018","journal-title":"Cell"},{"issue":"26","key":"8175_CR41","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.1523\/jneurosci.4278-06.2007","volume":"27","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Belyaev N, Conforti P, Ooi L, Tartari M, Papadimou E et al (2007) Widespread disruption of repressor element-1 silencing transcription factor\/neuron-restrictive silencer factor occupancy at its target genes in Huntington\u2019s disease. J Neurosci 27(26):6972\u20136983. https:\/\/doi.org\/10.1523\/jneurosci.4278-06.2007","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"8175_CR42","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/s0006-8993(00)02237-x","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Mar\u00edn C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866(1\u20132):257\u2013261. https:\/\/doi.org\/10.1016\/s0006-8993(00)02237-x","journal-title":"Brain Res"},{"issue":"5","key":"8175_CR43","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1523\/jneurosci.5100-09.2010","volume":"30","author":"S Rauskolb","year":"2010","unstructured":"Rauskolb S, Zagrebelsky M, Dreznjak A, Deogracias R, Matsumoto T, Wiese S et al (2010) Global deprivation of brain-derived neurotrophic factor in the CNS reveals an area-specific requirement for dendritic growth. J Neurosci 30(5):1739\u20131749. https:\/\/doi.org\/10.1523\/jneurosci.5100-09.2010","journal-title":"J Neurosci"},{"issue":"43","key":"8175_CR44","doi-asserted-by":"publisher","first-page":"11758","DOI":"10.1523\/jneurosci.2461-07.2007","volume":"27","author":"AD Strand","year":"2007","unstructured":"Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C et al (2007) Expression profiling of Huntington\u2019s disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27(43):11758\u201311768. https:\/\/doi.org\/10.1523\/jneurosci.2461-07.2007","journal-title":"J Neurosci"},{"issue":"2","key":"8175_CR45","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","volume":"105","author":"K Gharami","year":"2008","unstructured":"Gharami K, Xie Y, An JJ, Tonegawa S, Xu B (2008) Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington\u2019s disease phenotypes in mice. J Neurochem 105(2):369\u2013379. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05137.x","journal-title":"J Neurochem"},{"issue":"2","key":"8175_CR46","doi-asserted-by":"publisher","first-page":"e87923","DOI":"10.1371\/journal.pone.0087923","volume":"9","author":"D Todd","year":"2014","unstructured":"Todd D, Gowers I, Dowler SJ, Wall MD, McAllister G, Fischer DF et al (2014) A monoclonal antibody TrkB receptor agonist as a potential therapeutic for Huntington\u2019s disease. PLoS ONE 9(2):e87923. https:\/\/doi.org\/10.1371\/journal.pone.0087923","journal-title":"PLoS ONE"},{"issue":"1","key":"8175_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s42003-021-02304-w","volume":"4","author":"S Oura","year":"2021","unstructured":"Oura S, Noda T, Morimura N, Hitoshi S, Nishimasu H, Nagai Y et al (2021) Precise CAG repeat contraction in a Huntington\u2019s Disease mouse model is enabled by gene editing with SpCas9-NG. Commun Biol 4(1):771. https:\/\/doi.org\/10.1038\/s42003-021-02304-w","journal-title":"Commun Biol"},{"issue":"7","key":"8175_CR48","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1172\/JCI92087","volume":"127","author":"S Yang","year":"2017","unstructured":"Yang S, Chang R, Yang H, Zhao T, Hong Y, Kong HE et al (2017) CRISPR\/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington\u2019s disease. J Clin Invest 127(7):2719\u20132724. https:\/\/doi.org\/10.1172\/JCI92087","journal-title":"J Clin Invest"},{"issue":"3","key":"8175_CR49","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon SI, Huang Y, Ooi J et al (2017) Reversal of phenotypic abnormalities by CRISPR\/Cas9-Mediated gene correction in Huntington Disease patient-derived Induced Pluripotent Stem cells. Stem Cell Reports 8(3):619\u2013633. https:\/\/doi.org\/10.1016\/j.stemcr.2017.01.022","journal-title":"Stem Cell Reports"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-022-08175-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-022-08175-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:42:08Z","timestamp":1679870528000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-022-08175-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,23]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["8175"],"URL":"https:\/\/doi.org\/10.1007\/s11033-022-08175-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,23]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}